Rudd Brian D, Brien James D, Davenport Miles P, Nikolich-Zugich Janko
Department of Immunobiology and the Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ 85718, USA.
J Immunol. 2008 Oct 15;181(8):5199-203. doi: 10.4049/jimmunol.181.8.5199.
TLR ligands are among the key stimuli driving the optimal dendritic cell (DC) maturation critical for strong and efficacious T cell priming. In this study, we show that part of this effect occurs via increased TCR triggering. Pretreatment of DCs with TLR ligands resulted in the triggering of many more TCRs in responding CD8(+) T cells. Importantly, even when DCs expressed the same amount of cognate peptide-MHC (pMHC) molecules, TLR ligand treatment resulted in down-regulation of larger numbers of TCR molecules. This was independent of the up-regulation of costimulatory, adhesion or cytokine molecules or the amount of noncognate pMHCs. Rather, DCs pretreated with TLR ligands exhibited increased stability of cognate pMHCs, enabling extended TCR triggering. These findings are of potential importance to T cell vaccination.
Toll样受体(TLR)配体是驱动树突状细胞(DC)最佳成熟的关键刺激因素之一,而DC的最佳成熟对于强大而有效的T细胞启动至关重要。在本研究中,我们表明这种效应部分是通过增加T细胞受体(TCR)触发而发生的。用TLR配体预处理DC会导致反应性CD8(+) T细胞中更多的TCR被触发。重要的是,即使DC表达相同数量的同源肽-主要组织相容性复合体(pMHC)分子,TLR配体处理也会导致更多数量的TCR分子下调。这与共刺激分子、黏附分子或细胞因子分子的上调或非同源pMHC的数量无关。相反,用TLR配体预处理的DC表现出同源pMHC稳定性增加,从而能够延长TCR触发。这些发现对T细胞疫苗接种具有潜在的重要意义。